Gastric cancer is one of the most common cancers in the world. Animal models have been used to elucidate the details of the molecular mechanisms of various cancers. However, most inbred strains of mice have resistance to gastric carcinogenesis. Helicobacter infection and carcinogen treatment have been used to establish mouse models that exhibit phenotypes similar to those of human gastric cancer. A large number of transgenic and knockout mouse models of gastric cancer have been developed using genetic engineering. A combination of carcinogens and gene manipulation has been applied to facilitate development of advanced gastric cancer; however, it is rare for mouse models of gastric cancer to show aggressive, metastatic phenotypes required for preclinical studies. Here, we review current mouse models of gastric carcinogenesis and provide our perspectives on future developments in this field. 
Introduction
Gastric cancer is the second leading cause of death from cancer worldwide and is associated with a poor prognosis and a high incidence of drug resistance. 1, 2 The molecular mechanisms that promote gastric carcinogenesis are not yet fully understood. Gastric carcinomas can be divided into intestinal and diffuse types according to histological characteristics. 3 Intestinal-type carcinomas, which are thought to be derived from gastric mucosa cells, are histologically differentiated and exhibit well-defined glandular structures with expanding growth patterns developing through sequential stages, including chronic gastritis, atrophy, intestinal metaplasia (IM), spasmolytic polypeptide-expressing metaplasia (SPEM), dysplasia, and submucosal invasion; these changes are typical of precancerous epithelium. 4 On the other hand, diffuse-type carcinomas are histologically undifferentiated and have a diffuse infiltrative growth pattern, with tumor developing through a shorter, less well-characterized sequence of events from gastric epithelial cells. 5 Abate-Shen 6 suggested an association between development and gastric carcinogenesis. Inappropriate activation of specific developmental pathways seems to be involved in the development of IM and intestinal-type gastric carcinomas. An appropriate animal model needs to be developed in order to improve our understanding of the mechanisms involved in gastric cancer and to promote the discovery of novel therapeutic interventions. The gastric anatomy of mice is different from that of humans. In mice, the squamo-columnar junction does not universally approximate the gastro-esophageal junction as it does in normal human anatomy.
Moreover, rodents rarely develop spontaneous gastric cancer, although cotton rats (Sigmodon hispidus) and the Z strain of the African rodent Mastomys natalensis exhibit enterochromaffin-like cell carcinoids and develop gastric tumors more frequently. [7] [8] [9] [10] [11] Thus, studies have concentrated on the development of chemical, infectious, or genetic tools to induce gastric cancer in animals.
Here, we review chemically induced, Helicobacter infectioninduced, and genetic models of gastric carcinogenesis and compare their pathological patterns, limitations, and applications to improve our understanding of gastric carcinogenesis.
Chemical Carcinogen-Induced Models of Gastric Cancer
Establishment of adequate mouse models of gastric cancer is necessary for exploring the mechanisms of gastric tumorigenesis.
To this end, researchers have tested the utility of various chemical carcinogens to induce gastric cancer in mice. N-nitroso compounds (NOCs), which are generated in the stomach by anaerobic bacteria following ingestion of nitrates and nitrites, have been studied as cancer inducers. N-methyl-N-nitro-N-nitrosoguanidine (MNNG) has been used to induce stomach tumors in rats. For example, Schoental et al. 12 treated rats with MNNG using a stomach tube to induce formation of squamous cell carcinoma in the rat forestomach. Additionally, Sugimura and Fujimura 13 generated antropyloric adenocarcinomas with high frequency by administering MNNG orally to rats in drinking water. MNNG was found to be a very potent gastric carcinogen in Mongolian gerbils. 14, 15 Treatment with 400 ppm MNNG in drinking water for 50 weeks resulted in the development of gastric adenocarcinomas in 63.6% of gerbils. 15 However, because of the lack of genetic models using these animals, rats and gerbils have limited applications as model systems, and therefore, the effects of oral administration of nitrosamines has been investigated in inbred strains of mice. However, mice have been shown to have resistance to MNNG-induced gastric carcinogenesis. Indeed, when Balb/c mice were infected with H. heilmannii and administered MNNG in drinking water for 38 weeks, squamous cell carcinomas were found in the mouth and forestomach, but adenocarcinoma was not observed in the glandular stomach. 16 The ability of N-methyl-N-nitrosourea (MNU) to induce gastric carcinogenesis in mouse models has also been explored. Biweekly intragastric intubation with 0.5 mg MNU resulted in death of most Balb/c mice due to squamous cell carcinoma in the forestomach. Operative removal of the forestomach prior to MNU treatment helped to promote the development of well-differentiated adenocarcinoma in the glandular stomach, with a 100% incidence rate after 40 weeks of treatment. 17 Therefore, while glandular stomach is sensitive to the carcinogenic effects of MNU, this phenotype was not the result of the greater sensitivity of the forestomach to MNU under the investigated treatment conditions (dose and route of administration).
Tatematsu et al. 18 demonstrated that low-dose MNU ppm) given in drinking water was effective without the induction of tumors in the forestomach. The efficiency of tumor induction by MNU depends on its concentration rather than the total intake, 19 and MNU in the drinking water at 240 ppm for 5 weeks (every other week) has been shown to induce gastric cancer in six strains of mice. 20 Consequently, this protocol is used currently as a standard method for induction of gastric carcinogenesis in mice.
MNU-induced tumors in mice are located mainly in the gastric antrum and are uniformly well-differentiated adenocarcinomas. 21 The MNU mouse model of gastric cancer has been used for studying various signaling pathways in gastric carcinogenesis, including the roles of p53, 22 nuclear factor-kappaB (NF-κB), 23 
Helicobacter Infection Models
H. pylori are thought to be the main cause of chronic gastritis.
The first animal models of Helicobacter infection-induced carcinogenesis in the gastric mucosa was the ferret model. [34] [35] [36] Ferrets with H. mustalae infection exposed to 100 mg/kg MNNG developed gastric cancer, while H. mustalae-infected ferrets did not, 34 although MNNG-induced gastric cancer from H. mustalae-free SPF ferrets was not proven because these animals were not avail- In the H. felis infection model in mice, eradication studies have revealed that inflammation, metaplasia, and dysplasia are reversible when early eradication therapy is applied and that progression to dysplasia can be restricted with eradication therapy at a later time point. 50, 51 This phenomenon is linked to an epidemiological decrease in the incidence of gastric adenocarcinoma in humans. 52, 53 Gerbils and INS-GAS mice treated with antibiotics to eradicate H.
pylori exhibit arrested progression of gastric lesions. 43, 54 The Sydney strain of H. pylori (SS1) has been adopted as a useful strain in murine model systems. 55 
Genetically Engineered Mouse Models
Most genetic models in mice have been established on the C57BL/6 or mixed C57BL/6/129SvJ background. In the models discussed below, there are differences in tumor progression and phenotypes that are dependent on genetic background and gender.
As expected for inbred mouse populations, genetic variability in mouse strains produces different susceptibilities to the development of gastric cancers. Therefore, when using particular genetic models of gastric cancer, the use of wild-type control mice with genetic backgrounds identical to the mutant mice is crucial.
The epithelium of the mouse stomach comprises the proximal fundus and the distal antrum, and these tissues have distinct functions. The fundus produces acid for digestive enzymes, while the antrum has an endocrine and mucus-secretory role. Gastric tumors progress independently in separate regions under the control of different genetic triggers. Most of the models summarized in Table   2 57,70,72-141 produce various stages of tumors in either the fundus or the antrum, while some model produce tumors in both tissues. The genes exhibiting the highest levels of overexpression in the stomachs of TFF1 -/-mice are claudin 7 (encoding a tight junction protein), early growth response 1 (encoding a nuclear transcription factor), and epithelial membrane protein 1 (encoding a junctional membrane protein). 74 Upregulation of claudin 7 has also been observed in preneoplastic lesions in human stomachs and in gastric adenocarcinoma, thus underscoring the utility of the TFF1 -/-mouse model in the discovery of genes related to gastric cancer progression. Cancers develop in situ or intramucosal carcinoma 57 by reactivation of sonic hedgehog expression. 82 Inhibition of the gastrin/CCK2 and histamine H2 receptors limits the development of gastric cancer in these mice. 146 2) Actin-gastrin transgenic mice
The actin promoter has been used to drive gastrin expression in the Act-Gas transgenic model. these mice develop achlorhydria, hypergastrinemia, and hyperplasia, although the mechanism has not been directly tested. 94 Targeted mutation of Kcnq1 in mice leads to an expanded fundic proliferation zone with severe hyperplasia, achlorhydria, and hypergastrinemia. Several mouse lines with a defective Kcnq1 locus (14Gso) have been generated using random mutagenesis induced by X-ray irradiation of spermatogonia. 95 The products of these mutations are similar to those in H + /K + ATPase α-or β-null mutant mice.
4) Histamine receptor-knockout mice
The histamine histamine receptor (H2R) is expressed on acidsecreting parietal cells of the gastric mucosa and functions to stimulate gastric acid secretion. H2R-knockout mice are viable, fertile, and have normal basal gastric acid secretion, maintained by muscarinic receptors. 96 Fundic hyperplasia occurs as a direct product of increased numbers of parietal and enterochromaffin-like cell until 17 months of age, after which the pathology worsens to include mucocystic metaplasia, with a proportion of the mice developing herniation of the epithelium penetrating the muscularis mucosa and producing a phenotype closely mimicking Ménétrier's disease in humans. 97 
5) IQGAP1-knockout mice
Parietal cells in the gastric mucosa show subcellular reorganization upon activation, leading to secretion of gastric acid. Through its F-actin-binding function, IQGAP1 is involved in this subcellular reorganization event, which is dependent on the precise formation of F-actin structures by the Rho family of Ras-related GTPases. 
2) Transforming growth factor beta type II receptor dominant-negative transgenic mice
A dominant-negative transgene of the TGF β type II receptor was produced under control of the TFF1 promoter to direct stomach-specific expression. 149 These transgenic mice did not respond to TGF β ligands in the stomach, but also did not exhibit gastric abnormalities. However, infection with H. pylori induced the acquisition of a more severe phenotype in the fundus and antrum including greater hyperplasia, inflammation, and dysplasia, as well as intramucosal carcinoma.
3) SMAD4 hemizygous knockout mice 
4) ELF and SMAD4 double hemizygous knockouts
Embryonic liver fodrin (ELF), a novel β-spectrin, is a membrane-associated cytoskeletal component in cellular differentiation.
ELF plays a role as an adaptor for SMAD proteins. Loss of ELF disrupts nuclear translocation of SMAD3 and SMAD4. Mice with homozygous ELF4-deficiency die during embryonic development, and mice with heterozygous deletions for both SMAD4 and ELF
show a higher incidence of severe gastric lesions than those with mutations in SMAD4 alone. hyperplasia and glandular cystic dilation. 118, 119 This phenotype is reminiscent of the rare human condition Ménétrier's disease, which exhibits elevated TGF α expression. 118 In adult TGF α transgenic mice, the surface mucous cell population increases at the expense of both parietal and chief (zymogenic) cells, with the isthmuslocated stem cell zone nearer to the base of the glands, 120-122 and the mucosa become much more fibrotic. 123 Thus, the fundic mucosa phenocopies the antralization observed in precancerous metaplasia accompanying antral expression of Pdx1. 124 However, invasive gastric tumors with IM are not observed.
Dioxin/aryl hydrocarbon receptor transgenic mice
Activation of aryl hydrocarbon receptor (AhR) by environmental stimuli, such as dioxins and biphenyls, results in transcriptional activation of genes encoding xenobiotic metabolizing enzymes. 125 Endogenous expression of AhR is observed predominantly in the lungs, although mice transgenic for AhR also show expression of the transgene in the thymus, spleen, liver, skin, and stomach.
In AhR transgenic mice, cysts are grossly apparent in the fundic gastric mucosa at 3 months of age and develop into dysplastic structures that penetrated the muscularis mucosa into the submucosa and subserosa by 12 months of age, at which point trans-gene expression results in lethality. The penetrating mucosal cells exhibit a well-differentiated, benign appearance and seem to be invasive rather than a result of herniation. 125 Similar lesions have also been observed in laboratory animals following treatment with AhR ligands. 125 As cause of lesions, decreased expression of osteopontin has been detected in these fundic lesions in differential gene expression analyses. Because osteopontin is involved in tissue remodeling, invasive lesions may be caused by its altered expression in this mouse model. 126 In contrast, H 
p53 hemizygous knockout
p53 is a transcription factor that acts as a regulator of proliferation, apoptosis, and genomic repair. p53 hemizygous knockout mice have been shown to exhibit a low incidence of spontaneous carcinogenesis (2%) in organs. Infection with H. felis in hemizygous p53-knockout mice leads to an increased proliferative index and growth advantage compared with wild-type mice, but no obvious neoplasia was observed. 132 Moreover, wild-type C57BL/6 mice develop early invasive adenocarcinomas at 15 months after infection, with associated metaplasia and a greater inflammatory response. Therefore, hemizygosity of p53 appears to result in depressed Th1 immune responsiveness. 150 
SV40 T antigen transgenic mice
The SV40 T antigen from the simian virus is a potent trans- 
Nuclear factor-kappaB2-knockout mice
Supporting the role of the inflammatory system in regulating the gastric mucosa, loss of the COOH terminus of NF-κB2, an important transcription factor mediating inflammatory signals, has been shown to stimulate activation of Rel/NF-κB transcription factors. 141 These mice have antral epithelial tissue with severe hyperplasia at 3 weeks of age, resulting in premature death. [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] It is unclear which genes are affected by the increased activation of NF-κB, leading to this gastric phenotype. Additional studies are required to elucidate the details of these mechanisms.
Mouse Models of Preneoplastic Changes
H. pylori-related gastric cancer in humans is preceded by chronic gastritis, gastric atrophy, IM, and dysplasia. Thus, in addition to mouse models of gastric cancer, there are a number of genetically engineered models exhibiting decreased numbers of parietal cells or gastric atrophy, along with metaplasia. Several models of atrophy and metaplasia can be considered for use in experimental studies (Table 3) . 49, 80, 94, 121, 123, 124, 132, [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] However, most of these models do not show the progression to neoplasia and most have not been examined to assess susceptibility to cancer in response to carcinogens. Unfortunately, genetic models of metastatic gastric cancer similar to those developed for pancreatic cancer, comprising two or three mutations targeted to specific cell lineages, are not available. The major limitations of these models are minimal and include dispersion of promoter activity in the stomach and the lack of stomach-specific promoters that target antral progenitors only (Table 4) . [72] [73] [74] 79, 160, [163] [164] [165] [166] [167] [168] Reasonable mouse models of gastric cancer are available for studies of early-stage pathogenesis and cancer therapy, which have distinct mechanisms and different tumor phenotypes, with variations in the time course, location, and pathology of the disease.
Thus, researchers are able to utilize appropriate mouse models for their studies. Newly suggested research methods, including lineage tracing or genome-wide analysis, should prove valuable for understanding the causes of gastric cancer, and thereby facilitating the discovery of a cure for this disease.
